China Taiping Insurance Holdings Company Limited (CTIHY)

Other OTC - Other OTC Delayed Price. Currency in USD

27.85

0.00

(0.00%)

At close: 11:21AM EST

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	27.85
Open	27.45
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	27.85 - 27.85
52 Week Range	17.34 - 32.41
Volume	6
Avg. Volume	4

Market Cap	4.004B
Beta (5Y Monthly)	1.05
PE Ratio (TTM)	9.28
EPS (TTM)	3.00
Earnings Date	N/A
Forward Dividend & Yield	0.83 (2.99%)
Ex-Dividend Date	Jul 10, 2023
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CTIHY

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

CHINA TAIPING INSURANCE HOLDING
Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Rating
Fair Value
Economic Moat
10 months agoMorningstar